Sanofi
PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE

Last updated:

Abstract:

A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.

Status:
Application
Type:

Utility

Filling date:

6 Jul 2020

Issue date:

11 Feb 2021